Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saccharomyces Boulardii for NEC Prevention in VLBW Infants
NCT01315821Phase 3Unknown
- Sponsor
- Zekai Tahir Burak Women's Health Research and Education Hospital
- Start
- Feb 2011
- Primary completion
- Dec 2011
- Modality
- Microbiome Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of saccharomyces boulardii in necrotizing enterocolitis (NEC), sponsored by Zekai Tahir Burak Women's Health Research and Education Hospital. Status: unknown.
02
Drugs
saccharomyces boulardii
03
Conditions
necrotizing enterocolitis (NEC)
Beyond the preview
Go deeper on NCT01315821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01315821.